ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

DMAC DiaMedica Therapeutics Inc

2.39
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:15
15분 지연
기업명 주식 심볼 시장 주식 타입
DiaMedica Therapeutics Inc DMAC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.39 20:00:15
개장가 저가 고가 종가 전일 종가
2.39
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
04/06/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/06/202405:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/05/202405:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
24/05/202405:00EDGAR2Form 8-K - Current report
09/05/202405:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202405:30EDGAR2Form 8-K - Current report
09/05/202405:30BWDiaMedica Therapeutics Provides a Business Update and..
02/05/202421:55BWDiaMedica Therapeutics to Report First Quarter 2024..
18/04/202405:08BWDiaMedica Therapeutics Announces First Patient Dosed in..
20/03/202405:15BWDiaMedica Therapeutics Provides a Business Update and..
30/01/202406:13BWDiaMedica Therapeutics Announces Poster Presentation at..
24/01/202406:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/01/202422:23BWDiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as..
03/01/202407:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202306:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202306:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:52EDGAR2Form 8-K - Current report
14/11/202306:28BWDiaMedica Therapeutics Provides a Business Update and..
09/11/202322:25BWDiaMedica Therapeutics to Attend the 14th Annual..
06/11/202322:23BWDiaMedica Therapeutics to Report Third Quarter 2023..
12/09/202321:13BWDiaMedica Therapeutics Announces the Appointment of Ambarish..
06/09/202321:35BWDiaMedica Therapeutics to Participate at Lake Street’s 7th..
06/09/202305:15EDGAR2Form 8-K - Current report
15/08/202305:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/202305:25EDGAR2Form 8-K - Current report
15/08/202305:13BWDiaMedica Therapeutics Provides a Business Update and..
08/08/202321:32BWDiaMedica Therapeutics to Report Second Quarter 2023..
18/07/202321:30BWDiaMedica Therapeutics to Attend the American Academy of..
11/07/202305:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/07/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
01/07/202305:16EDGAR2Form S-3 - Registration statement under Securities Act of..
26/06/202321:30BWDiaMedica Therapeutics Announces Closing of $37.5 Million..
21/06/202321:39BWDiaMedica Therapeutics Announces $37.5 Million Private..
21/06/202321:15BWDiaMedica Therapeutics Announces that the FDA Has Removed..